231 related articles for article (PubMed ID: 18615481)
1. The impact of T and N stage on long-term survival of rectal cancer patients in the community.
Kozak KR; Moody JS
J Surg Oncol; 2008 Sep; 98(3):161-6. PubMed ID: 18615481
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome after operative intervention for rectal cancer in patients aged over 80 years: analysis of 9,501 patients.
Kiran RP; Pokala N; Dudrick SJ
Dis Colon Rectum; 2007 May; 50(5):604-10. PubMed ID: 17160571
[TBL] [Abstract][Full Text] [Related]
3. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
[TBL] [Abstract][Full Text] [Related]
4. Are survival rates different for young and older patients with rectal cancer?
O'Connell JB; Maggard MA; Liu JH; Etzioni DA; Ko CY
Dis Colon Rectum; 2004 Dec; 47(12):2064-9. PubMed ID: 15657655
[TBL] [Abstract][Full Text] [Related]
5. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
[TBL] [Abstract][Full Text] [Related]
6. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors.
Bufalari A; Giustozzi G; Burattini MF; Servili S; Bussotti C; Lucaroni E; Ricci E; Sciannameo F
J Surg Oncol; 2006 Mar; 93(3):173-80. PubMed ID: 16482596
[TBL] [Abstract][Full Text] [Related]
7. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of invasion, metastasis, and prognosis in low and middle rectal cancer].
He WJ; Wang L; Hu H; Kang SY; Qian HX; Xu FM
Ai Zheng; 2002 Nov; 21(11):1222-5. PubMed ID: 12526220
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen as a prognostic factor after total mesorectal excision of stage II-III rectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2009 Jun; 16(6):1494-500. PubMed ID: 19267156
[TBL] [Abstract][Full Text] [Related]
10. Lateral lymph node dissection for lower rectal cancer.
Shiozawa M; Akaike M; Yamada R; Godai T; Yamamoto N; Saito H; Sugimasa Y; Takemiya S; Rino Y; Imada T
Hepatogastroenterology; 2007 Jun; 54(76):1066-70. PubMed ID: 17629040
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of staging node-negative pancreas cancer: a potential quality measure.
Tomlinson JS; Jain S; Bentrem DJ; Sekeris EG; Maggard MA; Hines OJ; Reber HA; Ko CY
Arch Surg; 2007 Aug; 142(8):767-723; discussion 773-4. PubMed ID: 17709731
[TBL] [Abstract][Full Text] [Related]
12. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.
Jethanamest D; Morris LG; Sikora AG; Kutler DI
Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):276-80. PubMed ID: 17372086
[TBL] [Abstract][Full Text] [Related]
13. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer.
Kobayashi H; Ueno H; Hashiguchi Y; Mochizuki H
Surgery; 2006 Apr; 139(4):516-22. PubMed ID: 16627061
[TBL] [Abstract][Full Text] [Related]
14. Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?
Chapet O; Romestaing P; Mornex F; Souquet JC; Favrel V; Ardiet JM; d'Hombres A; Gerard JP
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1371-7. PubMed ID: 15817339
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients.
Coburn NG; Govindarajan A; Law CH; Guller U; Kiss A; Ringash J; Swallow CJ; Baxter NN
Ann Surg Oncol; 2008 Feb; 15(2):500-7. PubMed ID: 18026800
[TBL] [Abstract][Full Text] [Related]
16. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
17. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984.
Greenberg JA; Shibata D; Herndon JE; Steele GD; Mayer R; Bleday R
Dis Colon Rectum; 2008 Aug; 51(8):1185-91; discussion 1191-4. PubMed ID: 18536973
[TBL] [Abstract][Full Text] [Related]
18. Transanal endoscopic microsurgery in 143 consecutive patients with rectal adenocarcinoma: results from a Danish multicenter study.
Baatrup G; Breum B; Qvist N; Wille-Jørgensen P; Elbrønd H; Møller P; Hesselfeldt P
Colorectal Dis; 2009 Mar; 11(3):270-5. PubMed ID: 18573118
[TBL] [Abstract][Full Text] [Related]
19. Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience.
Hung FC; Kuo CM; Chuah SK; Kuo CH; Chen YS; Lu SN; Chang Chien CS
J Gastroenterol Hepatol; 2007 May; 22(5):724-8. PubMed ID: 17444863
[TBL] [Abstract][Full Text] [Related]
20. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.
Gosens MJ; van Krieken JH; Marijnen CA; Meershoek-Klein Kranenbarg E; Putter H; Rutten HJ; Bujko K; van de Velde CJ; Nagtegaal ID;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):997-1003. PubMed ID: 17544876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
